Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6035 Target Snapshot

Thioredoxin reductase 1, cytoplasmic · SINGLE PROTEIN · Rattus norvegicus

39,394Compounds
51Assays
0Approved Drugs
174.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O89049. Use UniProt O89049 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O89049 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Thioredoxin reductase 1, cytoplasmic as ChEMBL target CHEMBL6035, mapped to UniProt O89049. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Thioredoxin reductase 1, cytoplasmic
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL6035
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O89049
Thioredoxin reductase 1, cytoplasmic
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Thioredoxin reductase 1, cytoplasmic is the right protein anchor across sources, using UniProt O89049 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelThioredoxin reductase 1, cytoplasmic
UniProt AccessionO89049
Component TypeProtein
Sequence Length499 aa

Thioredoxin reductase 1, cytoplasmic

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Thioredoxin reductase 1, cytoplasmic, mapped to UniProt O89049. Sequence length is 499 aa.

Mapped IDO89049
Review nameThioredoxin reductase 1, cytoplasmic
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Phase I
Assay Mix

Activity Type Distribution

IC50153.0
KI2.0
EC5019.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2035489 6.89 IC50 130.0 Preclinical
CHEMBL4792536 6.72 IC50 190.0 Preclinical
CHEMBL285848 6.57 IC50 272.0 Preclinical
CHEMBL2034987 6.55 IC50 280.0 Preclinical
CHEMBL2035491 6.5 IC50 320.0 Preclinical
CHEMBL2035460 6.46 IC50 350.0 Preclinical
CHEMBL2035484 6.24 IC50 570.0 Preclinical
CHEMBL4745896 6.23 IC50 590.0 Preclinical
CHEMBL4459518 6.22 IC50 600.0 Preclinical
CHEMBL11475 6.16 IC50 700.0 Preclinical
Distribution

pChEMBL Value Distribution

31
5.0
24
5.5
11
6.0
5
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

51
Total Assays
109
Tested Compounds
2
Assay Types
Binding — 46 assays, 109 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 23 23 5.0
single protein format 22 53 5.2
tissue-based format 1 33 5.6
Functional — 5 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine